• Home
  • /
  • Athletics
  • /
  • Pisstake Ad Starring Disgraced Sprinter Ben Johnson Sparks Outrage

Pisstake Ad Starring Disgraced Sprinter Ben Johnson Sparks Outrage

Gavan Casey
By Gavan Casey
Share this article

A tv ad for an Australian betting company has sparked widespread outrage for making light of the use of performance enhancing drugs in sport.

The ad, which stars disgraced former sprinter Ben Johnson, makes a number of whimsical puns regarding PED usage.

Johnson was stripped of his 100-metre gold at the 1988 Seoul Olympics after he failed a drugs test. The mobile betting app which he's promoting in the add "tested positive for speed and power," according to the former runner himself. He also claims to have "put the roid in Android."

The ad also features a number of thinly-veiled references to doping in other sports, such as cycling, swimming and weight-lifting.

https://www.youtube.com/watch?v=QwD22vX9KSY

Recommended

Australia's anti-doping agency ASADA have released a statement condemning the ad:

The Australian Sports Anti-Doping Authority (ASADA) notes the current advertising campaign by online betting company, Sportsbet.

ASADA does not condone the message sent in this advertisement.

This advert makes light of the use of performance enhancing drugs in sport and sends the completely wrong message that the use of drugs in sport is normal.

This advertising campaign belittles the achievements of clean athletes and denigrates those who work to protect clean sport across the world.

ASADA has lodged a complaint about the advert with the relevant authority.

ASADA aren't the only party who have voiced their concern about the campaign.

Sportsbet, for what it's worth, don't seem to give a shit.

Advertisement

SEE ALSO: Olympic Silver Medalist Sets Diamond League Long Jump Record With Monster Leap

Join The Monday Club Have a tip or something brilliant you wanted to share on? We're looking for loyal Balls readers free-to-join members club where top tipsters can win prizes and Balls merchandise

Processing your request...

You are now subscribed!

Share this article

Copyright © 2024. All rights reserved. Developed by Square1 and powered by PublisherPlus.com

Advertisement